Join
Live feed
·
INSIDERFilingvia Quantisnow
CTI BioPharma Corp. (DE) logo

SEC Form 4: Metzger Michael A sold $130,995 worth of shares (20,121 units at $6.51) as part of a pre-agreed trading plan, closing all direct ownership in the company

ByQuantisnow·Wall Street's wire, on your screen.
CTIC· CTI BioPharma Corp. (DE)
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CTIC (CTI BioPharma Corp. (DE)) and more on Quantisnow.